Biotech Valueshttp://investorshub.advfn.com~/Biotech-Values-1418/Copyright Investorshub.com10<![CDATA[Checkpoint: REALLY.]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88082187http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88082187Mon, 20 May 2013 02:08:42 GMT<![CDATA[DewDiligence: Re: Upcoming biotech IPOs]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88081453http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88081453Mon, 20 May 2013 01:27:06 GMT<![CDATA[sayuncle: Hello all. I am new to the board]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88079012http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88079012Sun, 19 May 2013 22:55:39 GMT<![CDATA[goodJohnhunting: MD1225, goodjohn still feeling strong about Bavituximab? many have]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88078371http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88078371Sun, 19 May 2013 22:13:05 GMT<![CDATA[mcbio: EsperionTwo different drugs (eom).Thanks DD. Could be]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88078284http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88078284Sun, 19 May 2013 22:07:18 GMT<![CDATA[DewDiligence: Two different drugs (eom).]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88078265http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88078265Sun, 19 May 2013 22:05:55 GMT<![CDATA[mcbio: Esperion acquired other drugs that were in the]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88077753http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88077753Sun, 19 May 2013 21:30:58 GMT<![CDATA[drbio45: Esperion acquired other drugs that were in the]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88077677http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88077677Sun, 19 May 2013 21:25:16 GMT<![CDATA[goodJohnhunting: Pardon the late response, as I've been away]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88077464http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88077464Sun, 19 May 2013 21:05:46 GMT<![CDATA[haysaw: The New Science of Giving]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88072176http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88072176Sun, 19 May 2013 14:18:58 GMT<![CDATA[md1225: $PPHM mcbio your well read anyone else presenting]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88070593http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88070593Sun, 19 May 2013 10:27:15 GMT<![CDATA[mcbio: UPDATE: Esperion Therapeutics wants to go public too.]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88067874http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88067874Sun, 19 May 2013 03:29:58 GMT<![CDATA[DewDiligence: The premise for owning $MON was well-covered in]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88063338http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88063338Sat, 18 May 2013 20:40:14 GMT<![CDATA[CynicalTrader: UPDATED: PTC, Esperion, bluebird join the IPO frenzy]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88062149http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88062149Sat, 18 May 2013 19:02:19 GMT<![CDATA[DewDiligence: NVS’ Afinitor produced statsig PFS benefit in Herceptin-refractory]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88060891http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88060891Sat, 18 May 2013 17:22:37 GMT<![CDATA[ariadndndough : Bellicum in Trials with Cancer Vaccine, Cell-Suicide Switches]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88058192http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88058192Sat, 18 May 2013 13:36:02 GMT<![CDATA[north40000: $BTH and DEW: a link to a long]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88054753http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88054753Sat, 18 May 2013 04:40:49 GMT<![CDATA[mcbio: PYMXI wonder if someone will try to move]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88054360http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88054360Sat, 18 May 2013 04:04:55 GMT<![CDATA[BTH: Sounds like they're putting the screws to him,]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88053025http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88053025Sat, 18 May 2013 01:49:52 GMT<![CDATA[BTH: I am entirely in your camp, Checkpoint, regarding]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88052858http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88052858Sat, 18 May 2013 01:35:17 GMT<![CDATA[DewDiligence: Never seen a statement like this before:]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88052781http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88052781Sat, 18 May 2013 01:29:30 GMT<![CDATA[biotech_researcher: Thanks Dew, I followed suit.. $PKI profit]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88051738http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88051738Sat, 18 May 2013 00:05:56 GMT<![CDATA[biomaven0: "innovative” aspect of the trial]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88050970http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88050970Fri, 17 May 2013 23:08:09 GMT<![CDATA[mcbio: PRTA - 4Q12 CC notes (3/28/13)]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88050758http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88050758Fri, 17 May 2013 22:54:54 GMT<![CDATA[jq1234: GLPG0634 Crohn's maintenance measurement isn't really innovative. Humira]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88050357http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88050357Fri, 17 May 2013 22:27:12 GMT<![CDATA[jq1234: Nivolumab only $5B? For the record, Jaime Rubin]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88049136http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88049136Fri, 17 May 2013 21:22:20 GMT<![CDATA[WID: I currently hold shares of $LGND so I]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88047984http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88047984Fri, 17 May 2013 20:43:46 GMT<![CDATA[DewDiligence: I think you were asleep at the wheel]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88047887http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88047887Fri, 17 May 2013 20:41:12 GMT<![CDATA[Checkpoint: No sarcasm Dew, I think you were asleep]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88047677http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88047677Fri, 17 May 2013 20:35:17 GMT<![CDATA[jellybean: Viral load is not the endpoint to focus]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88046720http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88046720Fri, 17 May 2013 20:13:56 GMT<![CDATA[genisi: SNY announces that phase-3 for JAK2 inhibitor, SAR30250]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88046578http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88046578Fri, 17 May 2013 20:11:29 GMT<![CDATA[dav1234: Actavis' (ACT +1.5%) pursuit of Warner Chilcott ($WCRX]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88046546http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88046546Fri, 17 May 2013 20:10:47 GMT<![CDATA[genisi: Kamada already completed a phase II of it's]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88043677http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88043677Fri, 17 May 2013 19:25:05 GMT<![CDATA[DewDiligence: …Grifols is pursuing the CF indication while Kamada]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88043075http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88043075Fri, 17 May 2013 19:14:44 GMT<![CDATA[genisi: GRFS/inhaled AAT]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88042901http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88042901Fri, 17 May 2013 19:11:51 GMT<![CDATA[DewDiligence: I took profits today in my personal $PKI]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88042387http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88042387Fri, 17 May 2013 19:02:32 GMT<![CDATA[mcbio: GLPG: ]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88040333http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88040333Fri, 17 May 2013 18:24:47 GMT<![CDATA[ghmm: GLPG: I was doing a little research and it]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88040142http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88040142Fri, 17 May 2013 18:21:18 GMT<![CDATA[DewDiligence: FDA sets advisory committee meeting for Moxduo:]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88039323http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88039323Fri, 17 May 2013 18:05:21 GMT<![CDATA[ghmm: $LGND: I'm not a shareholder any longer, even if]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88039103http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88039103Fri, 17 May 2013 18:01:04 GMT<![CDATA[mcbio: GLPGIs maintenance measurement the “innovative” aspect of the]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88038776http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88038776Fri, 17 May 2013 17:54:19 GMT<![CDATA[DewDiligence: $LGND—It looks like you'll have to register with]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88038708http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88038708Fri, 17 May 2013 17:53:14 GMT<![CDATA[ghmm: $LGND: Not that I believe this (or suits like]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88038344http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88038344Fri, 17 May 2013 17:46:40 GMT<![CDATA[DewDiligence: Galapagos will start an innovative 20-week, Phase 2A/B]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88037276http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88037276Fri, 17 May 2013 17:25:43 GMT<![CDATA[mcbio: Galapagos - extends GLPG0634 collaboration]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88036907http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88036907Fri, 17 May 2013 17:18:22 GMT<![CDATA[DewDiligence: GRFS, the company that acquired Talecris in 2010,]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88036846http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88036846Fri, 17 May 2013 17:17:09 GMT<![CDATA[caravon: 1). Phase I study of ARQ197]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88036164http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88036164Fri, 17 May 2013 17:03:31 GMT<![CDATA[dav1234: Impax Laboratories (IPXL -1.2%) says its Generic Division,]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88035621http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88035621Fri, 17 May 2013 16:53:14 GMT<![CDATA[dav1234: Thoratec Corporation (THOR -1.5%) says it's received FDA]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88035531http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88035531Fri, 17 May 2013 16:51:36 GMT<![CDATA[DewDiligence: $SGMO—Why did you consider the results less than]]>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88035225http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88035225Fri, 17 May 2013 16:46:00 GMT